MYO6 Antibody
-
中文名稱：MYO6兔多克隆抗體
-
貨號：CSB-PA004696
-
規格：￥1090
-
圖片：
-
Western Blot analysis of Jurkat cells using Myosin VI Polyclonal Antibody
-
-
其他：
產品詳情
-
Uniprot No.：
-
基因名：MYO6
-
別名：Deafness autosomal recessive 37 antibody; DFNA 22 antibody; DFNA22 antibody; DFNB 37 antibody; DFNB37 antibody; KIAA0389 antibody; MYO 6 antibody; Myo6 antibody; MYO6_HUMAN antibody; Myosin VI antibody; Myosin-VI antibody; Myosin6 antibody; Unconventional myosin-6 antibody; Unconventional myosin-VI antibody
-
宿主：Rabbit
-
反應種屬：Human,Mouse,Rat
-
免疫原：Synthesized peptide derived from the N-terminal region of Human Myosin VI.
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Non-conjugated
-
抗體亞型：IgG
-
純化方式：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
-
產品提供形式：Liquid
-
應用范圍：WB, ELISA
-
推薦稀釋比：
Application Recommended Dilution WB 1:500-1:2000 ELISA 1:5000 -
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Myosin 6 is a reverse-direction motor protein that moves towards the minus-end of actin filaments. Has slow rate of actin-activated ADP release due to weak ATP binding. Functions in a variety of intracellular processes such as vesicular membrane trafficking and cell migration. Required for the structural integrity of the Golgi apparatus via the p53-dependent pro-survival pathway. Appears to be involved in a very early step of clathrin-mediated endocytosis in polarized epithelial cells. May act as a regulator of F-actin dynamics. As part of the DISP complex, may regulate the association of septins with actin and thereby regulate the actin cytoskeleton. May play a role in transporting DAB2 from the plasma membrane to specific cellular targets. May play a role in the extension and network organization of neurites. Required for structural integrity of inner ear hair cells. Modulates RNA polymerase II-dependent transcription.
-
基因功能參考文獻：
- Backfolding of MVI regulates its ability to bind DNA and that a putative transcription co-activator NDP52 relieves the auto-inhibition of MVI to enable DNA binding. Additionally, we show that the MVI-NDP52 complex binds RNAPII, which is critical for transcription, and that depletion of NDP52 or MVI reduces steady-state mRNA levels. PMID: 29187741
- The tumorigenic effect of lncRNA SOX21-AS1 in CRC cells via targeting miR-145/MYO6, providing a novel insight for CRC carcinogenesis. PMID: 29217166
- Rab33b, OATL1 and Myo6 have roles in nanoparticle trafficking in HeLa cells PMID: 27374232
- miR-143 and miR-145 suppress gastric cancer cell migration and metastasis by inhibiting MYO6 expression and the epithelial-mesenchymal transition, which provides a novel mechanism and promising therapeutic target for the treatment of gastric cancer metastasis. PMID: 29022908
- MYO6 facilitates Salmonella invasion.Salmonella virulence effector SopB requires MYO6 to regulate the localization of phosphoinositides and Akt activation. PMID: 28348208
- Data indicate filopodia formation and MYO6 motor function at endosomes and at the plasma membrane. PMID: 28143933
- we describe a novel nonsense MYO6 mutation that was responsible for the hearing loss in a Brazilian family PMID: 29044474
- this is the first ILDR1 and MYO6 mutations recognized in the southwest Iran. Our data expands the spectrum of mutations in ILDR1 and MYO6 genes PMID: 29224747
- MYO6 could play an essential role in the growth of OSCC cells via regulation of cell cycle progression and apoptosis. PMID: 27561828
- characterisation of the human myosin VI deafness mutant (R1166X) suggests that defects in cargo binding may leave myosin VI in a primed/activated state with an increased actin-binding ability PMID: 27474411
- PRAS40 was downregulated in the DU145 cells following MYO6 knockdown. PMID: 27431378
- knockdown of MYO6 slightly arrested cell cycle in G0/G1 phase, but remarkably increased the proportion of the sub-G1 phase of cell with the increase of apoptotic cells in colorectal cancer PMID: 27044563
- study indicates that MYO6 may play an important role in gastric cancer tumorigenesis and may serve as a potential therapeutic target in human gastric cancer. PMID: 27515005
- This study identified an isoform-specific regulatory helix, named the alpha2-linker, that defines specific conformations and hence determines the target selectivity of human myosin VI. PMID: 26950368
- Interaction of myosin VI and its binding partner DOCK7 plays an important role in NGF-stimulated protrusion formation in PC12 cells. PMID: 27018747
- Knockdown of myosin VI significantly suppressed melanoma cell viability and proliferation. PMID: 26324058
- Knockdown of MYO6 markedly reduced cell viability and colony formation, as well as suppressed cell cycle progression in breast cancer cells. PMID: 26407123
- MYO6 was highly expressed in hepatocellular carcinoma. PMID: 25703929
- MYO6 is crucial in maintaining cell cycle and cell growth of lung cancer cells.MYO6 is highly expressed in human lung cancer tissues. PMID: 25643992
- Optineurin binding to myosin VI was also decreased in tissue lysates from sporadic amyotrophic lateral sclerosis spinal cords. PMID: 25859013
- we demonstrate that myosin VI and TAX1BP1 are recruited to ubiquitylated Salmonella and play a key role in xenophagy PMID: 26451915
- The frameshift deletion in MYO6 was confirmed as the causative variant for this dominant nonsyndromic hearing loss DFNA22 family PMID: 25227905
- Several postulated mechanisms of function for actin cytoskeleton and MVI during subsequent steps of clathrin-dependent endocytosis are discussed in this review. PMID: 26263762
- Four mutations of MYO6 protein were found in seven Japanese families exhibiting autosomal dominant inheritance of hearing loss. PMID: 25999546
- Myosin VI mediates the movement of NHE3 to the microvillus in intestinal epithelial cells. PMID: 24928903
- In myopathies associated with fiber atrophy, the amount of MVI was enhanced and its localization in affected fibers was changed. PMID: 25125183
- Three mutations (p.R825X, p.R991X and Q918fsX941) produce a premature truncation of the myosin VI protein. p.R205Q, was associated with diminished actin-activated ATPase activity and actin gliding velocity of myosin VI in an in vitro analysis. PMID: 25080041
- The central regions of the cadherin tail adjacent to the juxtamembrane sequence also display binding activity for Myo VI-CBD. PMID: 23007415
- Myo6 plays a critical role in the fusion of endosome/lysosome in Rmc epithelial cells. Deficiency of myo6 compromises the epithelial barrier function PMID: 24028494
- we identified a novel MYO6 mutation at the splice acceptor site of exon 7 (c.554-1G>A) in an extended German family with autosomal dominant postlingual non-syndromic hearing impairment. PMID: 23635807
- Report Dutch family with progressive autosomal dominant sensorineural hearing loss caused by a mutation in MYO6 resembling presbyacusis. PMID: 23340379
- analysis of the dynamic exchange of myosin VI on endocytic structures PMID: 22992744
- It was shown that that myosin VI, in concert with Tom1, plays a crucial role in autophagy. Tom1 was identified as a myosin VI binding partner on endosomes. PMID: 23023224
- detailed kinetic characterization of the myosin-6 motor domain PMID: 22884421
- myosin VI regulates the organization of actin dynamics at the surface of a specialized organelle PMID: 22321127
- Studies from crystallographic structures of myosin VI have revealed that rearrangements within the converter subdomain occur. PMID: 22171985
- In this review, we describe the structure, kinetic properties and functions proposed for myosin VI, and present current hypotheses on the mechanisms of functioning of this unique protein in vivo. PMID: 21735821
- results suggest a novel role for myosin VI and optineurin in regulation of fusion pores formed between secretory vesicles and the plasma membrane during the final stages of secretion PMID: 21148290
- Role of insert-1 of myosin VI in modulating nucleotide affinity. PMID: 21278381
- In migratory cells ablation of myosin VI or optineurin inhibits the polarized delivery of the epidermal growth factor receptor into the leading edge and leads to profound defects in lamellipodia formation. PMID: 20604900
- Study suggests 2 tilt angles during myo6 stepping, corresponding to the pre- & post powerstroke states regulating leading head; large steps with hand-over-hand mechanism & small steps with inchworm-like mechanism increasing in frequency with ADP. PMID: 20850010
- Myosin VI is differentially regulated by DNA damage in p53- and cell type-dependent manners. PMID: 20576604
- This study describes the phenotype of 2 Belgian families with SNHL linked to DFNA22, both with a pathogenic change in the deafness gene MYO6. PMID: 19893302
- Our data indicate that miR-143 and miR-145 are involved in the regulation of MYO6 expression and possibly in the development of prostate cancer. PMID: 20353999
- Data show that downregulation of myosin VI expression results in a significant reduction in PSA and VEGF secretion in LNCaP cells, and the intracellular targeting seems to involve myosin VI-interacting proteins, GIPC and LMTK2 and Dab2. PMID: 19855435
- In families with recessively inherited deafness, DFNB37, our sequence analyses of MYO6 reveal a frameshift mutation (36-37insT), a nonsense mutation (R1166X), and a missense mutation (E216V) PMID: 12687499
- Results report the effects of the C442Y mutation on the kinetics of the actomyosin ATP hydrolysis mechanism and motor function of myosin VI. PMID: 15123708
- Inhibiting myosin VI expression in high-grade ovarian carcinoma cells impeded cell spreading and migration in vitro; optical imaging and histopathologic studies revealed that inhibiting myosin VI expression reduces tumor dissemination in nude mice PMID: 15146066
- myosin VI and Dab2 facilitate CFTR endocytosis by a mechanism that requires actin filaments PMID: 15247260
- a novel function for p53 in the maintenance of Golgi complex integrity and for myosin VI in the p53-dependent prosurvival pathway. PMID: 16507995
顯示更多
收起更多
-
相關疾?。?/div>Deafness, autosomal dominant, 22 (DFNA22); Deafness, autosomal recessive, 37 (DFNB37); Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy (DFNHCM)亞細胞定位：Golgi apparatus, trans-Golgi network membrane; Peripheral membrane protein. Golgi apparatus. Nucleus. Cytoplasm, perinuclear region. Membrane, clathrin-coated pit. Cytoplasmic vesicle, clathrin-coated vesicle. Cell projection, filopodium. Cell projection, ruffle membrane. Cell projection, microvillus. Cytoplasm, cytosol.; [Isoform 3]: Cytoplasmic vesicle, clathrin-coated vesicle membrane.; [Isoform 4]: Cytoplasmic vesicle, clathrin-coated vesicle membrane. Cell projection, ruffle membrane.蛋白家族：TRAFAC class myosin-kinesin ATPase superfamily, Myosin family組織特異性：Expressed in most tissues examined including heart, brain, placenta, pancreas, spleen, thymus, prostate, testis, ovary, small intestine and colon. Highest levels in brain, pancreas, testis and small intestine. Also expressed in fetal brain and cochlea. Is數據庫鏈接：
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
